134 related articles for article (PubMed ID: 37986995)
21. Viewpoint: a multidisciplinary approach to the assessment of patients with systemic sclerosis-associated interstitial lung disease.
Chatterjee S; Perelas A; Yadav R; Kirby DF; Singh A
Clin Rheumatol; 2023 Mar; 42(3):653-661. PubMed ID: 36271064
[TBL] [Abstract][Full Text] [Related]
22. Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
Yamakawa H; Takemura T; Iwasawa T; Yamanaka Y; Ikeda S; Sekine A; Kitamura H; Baba T; Iso S; Okudela K; Kuwano K; Ogura T
BMC Pulm Med; 2018 Jan; 18(1):25. PubMed ID: 29382307
[TBL] [Abstract][Full Text] [Related]
23. Responses to exercise in systemic sclerosis-associated interstitial lung disease.
Donnelly RP; Smyth AE; Mullan C; Riley MS; Nicholls DP
Clin Physiol Funct Imaging; 2023 Jul; 43(4):253-262. PubMed ID: 36660849
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary Artery Dimensions as a Prognosticator of Transplant-Free Survival in Scleroderma Interstitial Lung Disease.
Gleason JB; Patel KB; Hernandez F; Hadeh A; Highland KB; Rahaghi F; Mehta JP
Lung; 2017 Aug; 195(4):403-409. PubMed ID: 28456874
[TBL] [Abstract][Full Text] [Related]
25. miR-155 in the progression of lung fibrosis in systemic sclerosis.
Christmann RB; Wooten A; Sampaio-Barros P; Borges CL; Carvalho CR; Kairalla RA; Feghali-Bostwick C; Ziemek J; Mei Y; Goummih S; Tan J; Alvarez D; Kass DJ; Rojas M; de Mattos TL; Parra E; Stifano G; Capelozzi VL; Simms RW; Lafyatis R
Arthritis Res Ther; 2016 Jul; 18(1):155. PubMed ID: 27377409
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of interferon regulated and antiviral response genes in CD31+/CD102+ lung microvascular endothelial cells from systemic sclerosis patients with end-stage interstitial lung disease.
Piera-Velazquez S; Mendoza FA; Addya S; Pomante D; Jimenez SA
Clin Exp Rheumatol; 2021; 39(6):1298-1306. PubMed ID: 33253099
[TBL] [Abstract][Full Text] [Related]
27. CD19 + CD21
Wilfong EM; Vowell KN; Bunn KE; Rizzi E; Annapureddy N; Dudenhofer RB; Barnado A; Bonami RH; Johnson JE; Crofford LJ; Kendall PL
Clin Exp Med; 2022 May; 22(2):209-220. PubMed ID: 34374937
[TBL] [Abstract][Full Text] [Related]
28. Identification of Potential ceRNA Network and Patterns of Immune Cell Infiltration in Systemic Sclerosis-Associated Interstitial Lung Disease.
Wu Q; Liu Y; Xie Y; Wei S; Liu Y
Front Cell Dev Biol; 2021; 9():622021. PubMed ID: 34222222
[TBL] [Abstract][Full Text] [Related]
29. E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases.
Pulito-Cueto V; Remuzgo-Martínez S; Genre F; Atienza-Mateo B; Mora-Cuesta VM; Iturbe-Fernández D; Lera-Gómez L; Mora-Gil MS; Portilla V; Corrales A; Blanco R; Cifrián JM; González-Gay MA; López-Mejías R
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569893
[TBL] [Abstract][Full Text] [Related]
30. Ability of the COPD Assessment Test to evaluate the lung-specific quality of life in systemic sclerosis-associated interstitial lung disease.
Mugii N; Someya F
Clin Respir J; 2020 Jun; 14(6):527-532. PubMed ID: 32045097
[TBL] [Abstract][Full Text] [Related]
31. Mediators of systemic sclerosis-associated interstitial lung disease (SSc-ILD): systematic review and meta-analyses.
Fields A; Potel KN; Cabuhal R; Aziri B; Stewart ID; Schock BC
Thorax; 2023 Aug; 78(8):799-807. PubMed ID: 36261273
[TBL] [Abstract][Full Text] [Related]
32. Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease.
Volkmann ER; Tashkin DP; Roth MD; Clements PJ; Khanna D; Furst DE; Mayes M; Charles J; Tseng CH; Elashoff RM; Assassi S
Arthritis Res Ther; 2016 Dec; 18(1):305. PubMed ID: 28038680
[TBL] [Abstract][Full Text] [Related]
33. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review.
Petelytska L; Bonomi F; Cannistrà C; Fiorentini E; Peretti S; Torracchi S; Bernardini P; Coccia C; De Luca R; Economou A; Levani J; Matucci-Cerinic M; Distler O; Bruni C
RMD Open; 2023 Nov; 9(4):. PubMed ID: 37940340
[No Abstract] [Full Text] [Related]
35. High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studies.
Al-Adwi Y; Atzeni IM; Doornbos-van der Meer B; van der Leij MJ; Varkevisser RDM; Kroesen BJ; Stel A; Timens W; Gan CT; van Goor H; Westra J; Mulder DJ
EBioMedicine; 2023 Dec; 98():104883. PubMed ID: 37995465
[TBL] [Abstract][Full Text] [Related]
36. Antifibrotic efficacy of nintedanib in a cellular model of systemic sclerosis-associated interstitial lung disease.
Atanelishvili I; Akter T; Noguchi A; Vuyiv O; Wollin L; Silver RM; Bogatkevich GS
Clin Exp Rheumatol; 2019; 37 Suppl 119(4):115-124. PubMed ID: 31573469
[TBL] [Abstract][Full Text] [Related]
37. Interstitial lung disease associated with systemic sclerosis (SSc-ILD).
Cottin V; Brown KK
Respir Res; 2019 Jan; 20(1):13. PubMed ID: 30658650
[TBL] [Abstract][Full Text] [Related]
38. Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease.
Lee R; Reese C; Bonner M; Tourkina E; Hajdu Z; Riemer EC; Silver RM; Visconti RP; Hoffman S
Am J Physiol Lung Cell Mol Physiol; 2014 Apr; 306(8):L736-48. PubMed ID: 24583879
[TBL] [Abstract][Full Text] [Related]
39. Endothelial Progenitor Cells: Relevant Players in the Vasculopathy and Lung Fibrosis Associated with the Presence of Interstitial Lung Disease in Systemic Sclerosis Patients.
Pulito-Cueto V; Remuzgo-Martínez S; Genre F; Atienza-Mateo B; Mora-Cuesta VM; Iturbe-Fernández D; Lera-Gómez L; Pérez-Fernández R; Prieto-Peña D; Portilla V; Blanco R; Corrales A; Gualillo O; Cifrián JM; López-Mejías R; González-Gay MA
Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356910
[TBL] [Abstract][Full Text] [Related]
40. Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease.
Chung JH; Walker CM; Hobbs S
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32744514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
